The Hippo Pathway and YAP/TAZ–TEAD Protein–Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment

2015 ◽  
Vol 58 (12) ◽  
pp. 4857-4873 ◽  
Author(s):  
Matteo Santucci ◽  
Tatiana Vignudelli ◽  
Stefania Ferrari ◽  
Marco Mor ◽  
Laura Scalvini ◽  
...  
Cells ◽  
2021 ◽  
Vol 10 (10) ◽  
pp. 2715
Author(s):  
Evan R. Barry ◽  
Vladimir Simov ◽  
Iris Valtingojer ◽  
Olivier Venier

The Hippo pathway is an evolutionary conserved signaling network that regulates essential processes such as organ size, cell proliferation, migration, stemness and apoptosis. Alterations in this pathway are commonly found in solid tumors and can lead to hyperproliferation, resistance to chemotherapy, compensation for mKRAS and tumor immune evasion. As the terminal effectors of the Hippo pathway, the transcriptional coactivators YAP1/TAZ and the transcription factors TEAD1–4 present exciting opportunities to pharmacologically modulate the Hippo biology in cancer settings, inflammation and regenerative medicine. This review will provide an overview of the progress and current strategies to directly and indirectly target the YAP1/TAZ protein–protein interaction (PPI) with TEAD1–4 across multiple modalities, with focus on recent small molecules able to selectively bind to TEAD, block its autopalmitoylation and inhibit YAP1/TAZ–TEAD-dependent transcription in cancer.


2018 ◽  
Vol 72 (2) ◽  
pp. 328-340.e8 ◽  
Author(s):  
Han Han ◽  
Ruxi Qi ◽  
Jeff Jiajing Zhou ◽  
Albert Paul Ta ◽  
Bing Yang ◽  
...  

2020 ◽  
Vol 19 (7) ◽  
pp. 480-494 ◽  
Author(s):  
Anwesha Dey ◽  
Xaralabos Varelas ◽  
Kun-Liang Guan

2013 ◽  
Vol 13 (1) ◽  
pp. 119-131 ◽  
Author(s):  
Wenqi Wang ◽  
Xu Li ◽  
Jun Huang ◽  
Lin Feng ◽  
Keithlee G. Dolinta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document